Search Results - "El mrabet, Fatima Zahra"

Refine Results
  1. 1

    Sorafenib-Induced Erythema Multiforme Major and Severe Hepatic Failure in Metastatic Hepatocellular Carcinoma: A Case Report by Abrini, Houda, Amzerin, Mounia, El Mrabet, Fatima Zahra

    Published in Curēus (Palo Alto, CA) (29-03-2024)
    “…Sorafenib, a kinase inhibitor, is known to cause skin toxicity, which sometimes leads to treatment interruption or drug dose reduction. Erythema multiforme…”
    Get full text
    Journal Article
  2. 2

    Comparison of different Pancreatic cancer treatments: a three-year retrospective study in the oncology center of Tangier university hospital, Morocco by Abrini, Houda, Amzerin, Mounia, El Baaboua, Aicha, Aboulaghras, Sara, Bouhda, Alia, El Mrabet, Fatima Zahra

    Published in BMC gastroenterology (21-12-2023)
    “…Pancreatic cancer is among the most lethal malignancies, with a 5-year overall survival (OS) of less than 10% for all stages. The present study aims to…”
    Get full text
    Journal Article
  3. 3

    Intraperitoneal recurrence of renal haemangiopericytoma by El M'rabet, Fatima Zahra, Azegrar, Meryem

    Published in The Pan African medical journal (2017)
    “…The standard of care is surgery and it should be suggested even for recurrences, the management of locally advanced and metastatic disease consists on…”
    Get full text
    Journal Article
  4. 4

    Pathological complete response in advanced gastric stromal tumor after imatinib mesylate therapy: a case report by El Mesbahi, Omar, Brahmi, Sami Aziz, Akasbi, Yousra, El Mrabet, Fatima Zahra, Touyar, Anas, Ossaden, Abdelmalek, Znati, Kaoutar, Maazaz, Khalid, Amarti, Affaf, Tizniti, Siham, Taleb, Khalid Ait, Ibrahimi, Adil

    Published in Journal of medical case reports (21-05-2011)
    “…Gastrointestinal stromal tumors are a rare neoplasm exhibiting, in most cases, mutations of c-kit. Imatinib mesylate is the standard treatment for patients who…”
    Get full text
    Journal Article
  5. 5

    L’insuffisance ovarienne chimio-induite dans le cancer du sein : étude rétrospective de 100 cas by Amaadour, Lamiae, El Mrabet, Fatima Zahra, Atreche, Loubna, El Rhazi, Karima, Oualla, Karima, Benbrahim, Zineb, Arifi, Samia, Mellas, Nawfel

    Published in Bulletin du cancer (01-09-2020)
    “…Les cancers du sein touchent environ un quart des femmes en âge de procréer dans le monde. Les profils biomoléculaires observés dans les formes localisées…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Inflammatory breast cancer in Morocco: Experience of Hassan II University Hospital by Daoudi, Khaoula, Brahmi, Sami Aziz, Boudahna, Lamie, Hijri, Fatima Zahra, Bouyahia, Nezar, Oulla, Karima, Benhammane, Hafida, Chad, Amine Mohammed, El mrabet, Fatima Zahra, Arifi, Samia, Nawfel, Mellas, El Mesbahi, Omar

    Published in Journal of clinical oncology (20-05-2012)
    “…Abstract only e11516 Background: Inflammatory breast cancer (IBC) is the most virulent type of breast cancer. It represents 1 to 6% of all the breast cancer in…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Sorafenib-Induced Erythema Multiforme Major and Severe Hepatic Failure in Metastatic Hepatocellular Carcinoma: A Case Report by Abrini, Houda, Amzerin, Mounia, El Mrabet, Fatima Zahra

    Published in Cureus (01-03-2024)
    “…Sorafenib, a kinase inhibitor, is known to cause skin toxicity, which sometimes leads to treatment interruption or drug dose reduction. Erythema multiforme…”
    Get full text
    Report
  11. 11
  12. 12
  13. 13
  14. 14

    Neuroendocrine carcinoma of the cervix: a case report and review of the literature by Baggar, Soufiane, Ouahbi, Hajar, Azegrar, Meryem, El M'rabet, Fatima Zahra, Arifi, Samia, Mellas, Nawfel

    Published in The Pan African medical journal (2017)
    “…Small cell neuroendocrine carcinomas of the gynecologic tract are unusual, accounting for only 2% of the cervical cancers. Given the rarity of these tumors and…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20